Stocks in Action USA: Veeva, Okta, and Salesforce.
Reading Time: 3 minutes
Veeva (VEEV) exceeds expectations – AI offensive drives revenue and profit! The core of the growth story is the company's AI offensive. According to CEO Peter Gassner, artificial intelligence opens up the "next big chapter" for Veeva and the pharmaceutical industry: The central product Vault CRM (software for customer relationship management) recorded its best quarter ever and is now in use with more than 180 customers, including twelve of the 20 largest biopharmaceutical companies worldwide. Additionally, the agentic platform Veeva Falcon...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
